Black Rock Inc. Connect Biopharma Holdings LTD Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Connect Biopharma Holdings LTD stock. As of the latest transaction made, Black Rock Inc. holds 103,891 shares of CNTB stock, worth $94,540. This represents 0.0% of its overall portfolio holdings.
Number of Shares
103,891
Previous 1,040,067
90.01%
Holding current value
$94,540
Previous $1.81 Million
91.32%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CNTB
# of Institutions
17Shares Held
3.28MCall Options Held
14KPut Options Held
0-
Bml Capital Management, LLC Zionsville, IN2.09MShares$1.9 Million1.79% of portfolio
-
Ubs Oconnor LLC Chicago, IL511KShares$464,7370.04% of portfolio
-
Choreo, LLC Minneapolis, MN161KShares$146,3880.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny135KShares$122,5740.0% of portfolio
-
Royal Bank Of Canada Toronto, A680.4KShares$73,1640.0% of portfolio
About Connect Biopharma Holdings Ltd
- Ticker CNTB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,015,800
- Market Cap $50.1M
- Description
- Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...